Literature DB >> 21353582

Management of thoracic esophageal perforations.

Douglas J Minnich1, Patrick Yu, Ayesha S Bryant, Doraid Jarrar, Robert J Cerfolio.   

Abstract

OBJECTIVE: To assess our results of a prospective algorithm applied to patients with thoracic esophageal perforation.
METHODS: A retrospective review of a prospective algorithm. Patients with esophageal perforation underwent an esophagram. If there was a contained esophageal perforation they were admitted, kept nothing by mouth, and restudied in 3-5 days. If the leak was not contained, they underwent operative repair.
RESULTS: From 1/1998 to 6/2009 there were 81 patients. The gastrograffin swallow showed 56 patients had contained perforations and 25 did not. Twenty-two of the 25 patients with noncontained perforation underwent immediate operative repair (one patient refused surgery, two were not stable enough for the operating room); their morbidity was 68% and there were six (24%) operative mortalities. Median hospital length of stay (LOS) was 11 days (range, 2-120). Of the 56 patients with contained perforations, 26 were managed successfully without surgery. However, 30 of the patients initially treated nonoperatively eventually required operations due to new pleural effusion, mediastinal abscess, or conversion to noncontained perforation. Their morbidity was 41% and there were three operative mortalities (5%). On univariate analysis, these patients were more likely to have undergone previous esophageal procedures (surgical or dilation) (p=0.03), had new or increased pleural effusion (p=0.04), and had greater than 24h between diagnosis and treatment (p=0.02). Only greater than 24h between diagnosis and treatment remained a significant predictor on multivariate analysis. Their median hospital LOS was 21 days (range, 7-77).
CONCLUSION: Contained thoracic esophageal perforations can usually be safely managed nonoperatively without significant morbidity or mortality. However, careful in-hospital monitoring is needed if surgery is not chosen. Published by Elsevier B.V.

Entities:  

Mesh:

Year:  2011        PMID: 21353582     DOI: 10.1016/j.ejcts.2010.12.066

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  8 in total

Review 1.  Esophageal perforation: a research review of the anti-infective treatment.

Authors:  Jennifer Gregory; Jason Hecht
Journal:  Int J Clin Pharm       Date:  2018-06-28

2.  Novel esophageal stent for treatment of cervical anastomotic leakage after esophagectomy.

Authors:  Gang Wu; Meipan Yin; Yan Shi Zhao; Yi Fang; Gaofeng Zhao; Jia Zhao; Xinwei Han
Journal:  Surg Endosc       Date:  2017-04-21       Impact factor: 4.584

3.  Management of thoracic esophageal perforation.

Authors:  Yidan Lin; Guangliang Jiang; Lunxu Liu; Jack Xiwen Jiang; Longqi Chen; Yongfan Zhao; Junjie Yang
Journal:  World J Surg       Date:  2014-05       Impact factor: 3.352

4.  When gastroenteritis isn't: a case report of a 20-year-old male with Boerhaave's syndrome complicated by intra-abdomimal hemorrhage.

Authors:  James Baird; Alexander B Norinsky
Journal:  World J Emerg Med       Date:  2016

5.  Factors affecting perforation of the esophagus in patients with deep neck infection.

Authors:  Shih-Lung Chen; Chia-Ying Ho; Shy-Chyi Chin; Yu-Chien Wang
Journal:  BMC Infect Dis       Date:  2022-05-27       Impact factor: 3.667

Review 6.  Current treatment and outcome of esophageal perforations in adults: systematic review and meta-analysis of 75 studies.

Authors:  Fausto Biancari; Vito D'Andrea; Rosalba Paone; Carlo Di Marco; Grazia Savino; Vesa Koivukangas; Juha Saarnio; Ersilia Lucenteforte
Journal:  World J Surg       Date:  2013-05       Impact factor: 3.352

7.  Current treatment and outcome of esophageal perforation: A single-center experience and a pooled analysis.

Authors:  Yufeng Deng; Luqi Hou; Dianyue Qin; Ting Huang; Tianzhu Yuan
Journal:  Medicine (Baltimore)       Date:  2021-04-23       Impact factor: 1.817

8.  Esophageal stents for less invasive treatment of mediastinitis.

Authors:  Jarmil Safranek; Jan Geiger; Vladimir Vesely; Josef Vodicka; Vladislav Treska
Journal:  Wideochir Inne Tech Maloinwazyjne       Date:  2014-01-25       Impact factor: 1.195

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.